UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization

Human pathology, 2019-11, Vol.93, p.65-73

2019

Volltextzugriff (PDF)

Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma

The oncologist (Dayton, Ohio), 2019-10, Vol.24 (10), p.1356-1367

2019

Volltextzugriff (PDF)

Complete Remission Following Pembrolizumab in a Woman with Mismatch Repair‐Deficient Endometrial Cancer and a Germline BRCA1 Mutation

The oncologist (Dayton, Ohio), 2018-06, Vol.23 (6), p.650-653

2018

Volltextzugriff (PDF)

Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms

Human pathology, 2019-04, Vol.86, p.1-11

2019

Volltextzugriff (PDF)

BRAFV600E Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence

World journal of surgery, 2020-08, Vol.44 (8), p.2685-2691

2020

Volltextzugriff (PDF)

Tau phosphorylation sites work in concert to promote neurotoxicity in vivo

Molecular biology of the cell, 2007-12, Vol.18 (12), p.5060-5068

2007

Volltextzugriff (PDF)

Case report: Extending the spectrum of clinical and molecular findings in FOXC1 haploinsufficiency syndrome

Frontiers in genetics, 2023, Vol.14, p.1174046

2023

Volltextzugriff (PDF)

S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila

Journal of neuroscience research, 2007-05, Vol.85 (6), p.1271-1278

2007

Volltextzugriff (PDF)

Prognostic Roles of BRAF, KIT, NRAS, IGF2R and SF3B1 Mutations in Mucosal Melanomas

Cells (Basel, Switzerland), 2021-08, Vol.10 (9), p.2216

2021

Volltextzugriff (PDF)

Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A - MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma

JCO precision oncology, 2020-11 (4), p.109-115

2020

Volltextzugriff (PDF)

Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer

Cancer discovery, 2018-04, Vol.8 (4), p.417-427

2018

Volltextzugriff (PDF)

Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor

NPJ precision oncology, 2017-03, Vol.1 (1), p.5-5, Article 5

2017

Volltextzugriff (PDF)

A Novel SEC22B-NOTCH2 Fusion in Chronic Lymphocytic Leukemia

Human pathology : case reports, 2020-09, Vol.21, p.200408, Article 200408

2020

Volltextzugriff (PDF)

Longitudinal molecular analysis of tumor exome and transcriptome to evaluate clonal evolution and identify novel therapeutic targets in thymoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e20624-e20624

2022

Volltextzugriff (PDF)

Mucoacinar Carcinoma: A Rare Variant of Mucoepidermoid Carcinoma

The American journal of surgical pathology, 2021-08, Vol.45 (8), p.1028-1037

2021

Volltextzugriff (PDF)

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

Cancer discovery, 2012-03, Vol.2 (3), p.227-235

2012

Volltextzugriff (PDF)

Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma

Thyroid (New York, N.Y.), 2020-09, Vol.30 (9), p.1384-1389

2020

Volltextzugriff (PDF)

GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis

Modern pathology, 2024-02, Vol.37 (2), p.100386-100386, Article 100386

2024

Volltextzugriff (PDF)

75. Clinical implementation of a precision medicine consultation service

Cancer genetics, 2022-11, Vol.268-269, p.24-25

2022

Volltextzugriff (PDF)

Immunohistochemical Detection of NRAS Q61R Mutation in Diverse Tumor Types

American journal of clinical pathology, 2016-01, Vol.145 (1), p.29-34

2016

Volltextzugriff (PDF)

GE-05 EXOME SEQUENCING REVEALS BRAF MUTATIONS IN PAPILLARY CRANIOPHARYNGIOMAS

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v97-v97

2014

Volltextzugriff (PDF)

The landscape of clinically actionable ALK/MET/RET/ROS1 fusions to reveal a shared pattern of protein domains in fusion partners

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.11560-11560

2016

Volltextzugriff (PDF)

Primary Benign and Malignant Thyroid Neoplasms With Signet Ring Cells

American journal of clinical pathology, 2017-09, Vol.148 (3), p.251-258

2017

Volltextzugriff (PDF)

Tumor genomics and response to CDK 4/6 inhibitors for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1046-1046

2017

Volltextzugriff (PDF)

Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles

Cancers, 2021-03, Vol.13 (7), p.1621

2021

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(63)
Berichte
(1)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization

Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma

Complete Remission Following Pembrolizumab in a Woman with Mismatch Repair‐Deficient Endometrial Cancer and a Germline BRCA1 Mutation

Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms

BRAFV600E Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence

Tau phosphorylation sites work in concert to promote neurotoxicity in vivo

Case report: Extending the spectrum of clinical and molecular findings in FOXC1 haploinsufficiency syndrome

S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila

Prognostic Roles of BRAF, KIT, NRAS, IGF2R and SF3B1 Mutations in Mucosal Melanomas

Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A - MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma

Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer

Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor

A Novel SEC22B-NOTCH2 Fusion in Chronic Lymphocytic Leukemia

Longitudinal molecular analysis of tumor exome and transcriptome to evaluate clonal evolution and identify novel therapeutic targets in thymoma

Mucoacinar Carcinoma: A Rare Variant of Mucoepidermoid Carcinoma

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma

GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis

75. Clinical implementation of a precision medicine consultation service

Immunohistochemical Detection of NRAS Q61R Mutation in Diverse Tumor Types

GE-05 EXOME SEQUENCING REVEALS BRAF MUTATIONS IN PAPILLARY CRANIOPHARYNGIOMAS

The landscape of clinically actionable ALK/MET/RET/ROS1 fusions to reveal a shared pattern of protein domains in fusion partners

Primary Benign and Malignant Thyroid Neoplasms With Signet Ring Cells

Tumor genomics and response to CDK 4/6 inhibitors for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles

Aktive Filter

Suchergebnisse filtern